We have previously demonstrated that myofibroblasts from lungs with bleomycin-induced fibrosis overexpress FasL molecules. Two subpopulations of fibroblasts, distinguished by their expression of Thy1 molecules, have been shown in the lungs of both mice and humans. Thy1-mediated FasL induction has been reported in T cells through the use of anti-Thy1 (G7). We therefore sought to determine whether FasL expression in lung myofibroblasts is associated with and/or dependent on Thy1 expression, and to examine the underlying mechanism of regulation.
Introduction
FasL is a cell surface molecule belonging to the TNF family (1) , whose main function is to induce apoptosis through binding to the Fas receptor (2) . The Fas/FasL interaction plays a role in the pathophysiology of several diseases, including idiopathic pulmonary fibrosis (IPF) (3) . FasL is predominantly induced in immune cells during activation of the immune system (4, 5) , but was also shown to be constitutively expressed on nonimmune cells, including immune-privileged tissues (6) , and tumors (7) . In fibroblasts, FasL upregulation has been demonstrated in experimental murine bleomycin-induced scleroderma in the skin (8) , and in skin allografts (9) .
Because FasL is such a potent apoptosis mediator, surface expression of FasL must be tightly regulated. Studies show, that FasL expression is regulated at several levels: transcriptional (6, 10) and post-translational, e.g. cleavage of surface FasL by metalloprotease (11, 12) . Several stimuli, such as retinoic acid (9) , irradiation (13) , and cytokines, induce FasL expression (14, 15) . In T cells, FasL is also known to be upregulated by cross-linking of TCR or Thy1 surface protein (16) .
Thy1 is a 25-37 kDa glycosylphosphatidylinositol (GPI)-anchored cell surface protein that belongs to the immunoglobulin-like gene super family (17) . Thy1 is involved in T cell activation of both immunological (18) , and nonimmunological functions (19) . To mediate these effects, Thy1 signals through multiple pathways, including Src family kinases (SFKs) (18, 20) . It has been shown that Thy1 associates with SFK members fyn, lyn, and lck (21, 22) , which were shown to mediate FasL upregulation by various stimuli, such as TCR (23) or irradiation (13) .
Thy1 is expressed on various cell types, including fibroblasts (18) . In the lungs of mice and humans, there are two subpopulations of fibroblasts, which are distinguished by the expression of Thy1 (24, 25) . Thy1 + and Thy1 -fibroblasts differ with respect to size and shape (25) , expression of-and response to cytokine and growth factors (19, 26, 27) , resistance to apoptosis in response to collagen contraction (27) , and expression of A-SMA (19, 26, 27) , as well as cellular migration (28) .
We have recently demonstrated that myofibroblasts from bleomycin-treated mice overexpress FasL molecule, and act as effector cells that induce apoptosis in Fas + epithelial cells (29) and lymphocytes (30) via Fas/FasL interaction. (29) . Moreover, we have demonstrated that FasL expression on lung myofibroblasts facilitates emergence of a phenotype of escape from in vivo immune surveillance as a mechanism for tissue fibrosis (30) .
In this study we aimed to detect differences in FasL expression in the two myofibroblast subsets, as well as to study whether Thy1 has a role in the regulation of FasL expression in lung myofibroblasts, and by which mechanism.
Animals
Eleven-to-12 wk old, male, C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) and C57BL/6J Thy1 -mice were used (Provided by Dr. R.J. Morris, Nosten-Bertrand, M1996, Mayeux-Portas V 2000). All animal procedures were approved by the Hebrew UniversityHadassah Medical School Animal Care Committee. Mice were housed in a specific pathogenfree environment.
Intratracheal instillation
The intratracheal (IT) techniques used in this analysis have been previously described by our lab (29, 30) . Briefly, mice were anesthetized by injection of 0.05-0.07 ml of 40 mg/ml Ketalar ip (Parke-Davis, Pontypool, Gwent, UK) and 0.5 mg/ml Droperidol (Janssen Pharmaceutica, Beerse, Belgium). The skin and subcutaneous tissues overlying the proximal portion of the trachea were exposed by a 5-mm transverse incision to allow for direct external visualization of the trachea. A metal cannula fitted to a tuberculin syringe was carefully passed into the trachea. A dose of 0.06-0.08 units of bleomycin (H. Lundbeck, Copenhagen, Denmark) dissolved in 0.1 ml of saline solution, or 0.1 ml of saline alone, was slowly injected. For confirmation of fibrosis, we performed assays of the extent of inflammation in broncheoalveolar fluid, and histopathology, as we previously describe in detail (30) .
Lung cell isolation and myofibroblast culture
Techniques used in this research have been previously described by our lab (29, 30) . Briefly, mice were killed with a lethal dose of pentobarbital. Lungs were removed, minced, and incubated (37°C, 5% CO 2 air) for 45 min in PBS containing 1 mg/ml collagenase (C0130, Sigma-Aldrich, St Louis, MO). After enzyme treatment, lung tissue was gently passed through a cell dissociation sieve (Sigma-Aldrich), then washed twice in PBS. For myofibroblast culture experiments, lung cells (LC) were resuspended in fibroblast culture medium (RPMI 1640, Sigma-Aldrich) supplemented with 10% FCS, 100 Lg/ml penicillin, 100 mg/ml streptomycin, 25 mM HEPES buffer, 2 mM L-glutamine, 50 µg/ml gentamicin sulfate, nonessential amino acids (Biological Industries, Beit Haemek, Israel), and 5 x l0 
RNA isolation
Total cellular RNA was isolated from myofibroblasts in culture, using TriReagent (T9424, Sigma), according to the protocol supplied by the manufacturer. To assess RNA integrity and exclude DNA contamination, an aliquot of each sample was analyzed by 1% agarose gel electrophoresis. Purity and quantitation of RNA was assessed by spectophotometer.
RT-PCR
RNA was reverse transcribed to cDNA using an avian myeloblastosis virus-RT base protocol and random primers, as well as poly (dT) (Reverse Transcription System; Promega, Madison, WI). One microgram of each sample was uniformly used for reverse transcription. The cDNA was diluted in a final volume of 200 µl with nuclease-free water.
Real-time PCR
For TaqMan real-time PCR, FasL, 18S primers, and a TaqMan probe were purchased from Applied BioSystems (Foster City CA). The probe sequences of the genes analyzed were: 
Immunoblot analysis
Cell samples were homogenized in RIPA buffer (1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS in Tris-buffered saline), including a protease inhibitor cocktail (Sigma-Aldrich) and a phosphathase inhibitor cocktail (Sigma-Aldrich). Alternatively, for detection of phosphorylation, we used NP-40 lysis buffer (1% NP-40, 20mM Tris pH 7.5, 150mM Nacl, 0.1 % NaN 3 ) , including a protease inhibitor cocktail, as well as Na vanadate (Sigma-Aldrich) and PMSF (Sigma-Aldrich).
Lysates were then separated by 10% sodium dodecyl sulfate polyacrylamide gel elctrophoresis under reducing conditions. After electrophoresis, samples were transferred to a nitrocellulose membrane (BioRad, Hercules CA). The membranes were blocked with 5% dry milk in Tris- 
Antibody array
An antibody array (Hypomatrix, Worcester MA) containing specific antibodies for detection of a range of signal transduction molecules and kinases, was used to study the SFK specific protein profile of phosphorylation in lung myofibroblasts following activation with anti-Thy1 mAb. Briefly, the antibody array was blocked with 5% dry milk in Tris-buffered saline/Tween-20 (0.1 %) (TBS-T) for 1 h at RT. The antibody array was then incubated for 2 h at RT with lysates obtained, as described above, from primary myofibroblast cultures stimulated with 10 µg/ml G7 anti-Thy1 mAb or control IgG isotype match for 10 min. The membrane was washed with PBS and blotted with HRP-conjugated anti-Phosphotyrosine RC20 (2 µg/ml) (BD Transduction Laboratories, Franklin Lakes NJ) for 2h at RT followed by ECL detection, and the phosphorylation level of SFKs proteins was quantitated. These steps are described above.
Transfection
Small interference RNA (siRNA) against Fyn, or nontargeting siRNA were purchased from Qiagen (Valencia CA, Cat #SI01007398and 1027281 respectively). For electroporation, the cells were harvested and washed twice with ice-cold phosphate-buffered saline (PBS) (Mg 
Measurement of NO -
After cytokine stimulation, NO -production was monitored by measuring nitrite levels in culture media using the Griess reagent system (Promega, Madison, WI), according to the manufacturer's protocol. Absorbance was measured at 540 nm after incubating the culture media with Griess reagent.
Statistical analysis
Comparison of FasL mRNA levels between IgG and anti-Thy1 treatment groups was assessed using the nonparametric Wilcoxon rank-sum test.
Results

The association between Thy1 and FasL upregulation in bleomycin-treated lung myofibroblasts
We determined whether FasL upregulation in lung myofibroblasts is associated with Thy1 expression. FasL expression was analyzed in Thy1 (Fig. 1) .
FasL upregulation on myofibroblasts is Thy1 dependent
To test the critical role Thy1 plays on myofibroblast FasL upregulation, we assessed changes in FasL expression in myofibroblasts isolated from the lungs of bleomycin-treated WT and Thy1-deficient mice. Flow cytometry analysis showed increased FasL expression in myofibroblasts from WT mice compared to those from Thy1-deficient mice (Fig. 2) .
Thy1 activation induces FasL upregulation in lung myofibroblasts
In order to test whether myofibroblast FasL expression is a result of a direct Thy1 activation, primary lung myofibroblasts isolated from WT, and Thy1 -deficient C57BL/6 mice were stimulated with (1-20 µg/ml) G7 anti-Thy1 mAb, which has been previously shown to induce FasL expression in T cells (16) . Following Thy1 activation, cells were stained with PEconjugated anti-FasL mAb. Flow cytometry analysis showed that FasL expression was enhanced by Thy1 stimulation in a dose-dependent manner in WT (Fig. 3A) , but not in Thy1-deficient myofibroblasts (Fig. 3B) .
IFN-( and TNF-) cytokines do not induce FasL upregulation in lung myofibroblasts
IFN-B and TNF-A have been shown to be the main cytokines inducing FasL expression (14, 15) .
In order to assess whether these cytokines play a role in lung myofibroblast FasL expression, primary myofibroblasts isolated from WT and Thy1 deficient naïve mice were stimulated with IFN-B, TNF-A, or a combination of IFN-B and TNF-A, for 24 h. Despite nitrite (NO 2 ) production following myofibroblast activation by these cytokines (Fig. 4 insert) , no significant increase in (Fig. 4) .
Lung myofibroblast Thy1 activation mediates FasL translocation to the cell surface
Thy1 antibody (5 µg/ml) mediated activation of myofibroblast showed overexpression of cell surface FasL at 10, 20, 30, and 60 min. Dose response data at 60 min is presented (Fig. 3) . In order to assess whether this rapid Thy1-induced FasL overexpression on the cell membrane results from a mechanism of translocation of cytosolic FasL from the cytosol to the surface cell membrane, rather than from the upregulation of gene transcription or protein synthesis (see Fig.   6 ), cellular FasL distribution was studied 1 hour after anti-Thy1 stimulation. More intense cell membrane staining was detected in Thy1-activated myofibroblasts compared to IgG controls (Fig. 5A) . Similarly, FACS analysis of Thy1-activated myofibroblasts showed increased staining of membranal FasL, with no difference in total (membranous and cytoplasmatic) FasL staining (Fig. 5B ).
Thy1-mediated FasL transcriptional and translational regulation
In order to assess whether Thy1 is also involved in the regulation of FasL at the transcriptional and/or translational level, we periodically measured both FasL mRNA and protein levels from 30 min to 72 h after anti-Thy1 stimulation. FasL mRNA levels were upregulated only after 1 h of stimulation (Fig. 6A) , and protein levels increased at 24 h (Fig. 6B ).
These results demonstrate that Thy1 activation leads to rapid membranal FasL overexpression by FasL translocation from the cytosol, whereas at a later stage Thy1 activation induces de novo synthesis of FasL mRNA and protein.
Thy1 mediates FasL upregulation via Src family kinases (SFKs)
SFKs (Src family kinases) are nonreceptor tyrosine kinases that are known to mediate Thy1 signaling in T cells (20) . In order to study SFK involvement in Thy1 signal transduction, leading to FasL upregulation in lung myofibroblasts, we assessed Src phosphorylation (normalized to total Src) following Thy1 stimulation. Thy1 stimulation induced Src phosphorylation (Fig. 7A) .
Moreover, pretreatment of myofibroblasts with Src kinase inhibitor (PP2) inhibited Thy1-induced FasL upregulation, as assessed by flow cytometry (Fig. 7B ).
Thy1-induced upregulation of FasL is mediated by Fyn
We then determined which of Src family kinases is involved in Thy1-induced upregulation of FasL in lung myofibroblasts. For this purpose we initially assessed the extent of phosphorylation µg/ml G7 anti-Thy1 mAb or IgG control. Whole cell lysates were subjected to an array of antibodies against SFK proteins and further immonoblotted with anti tyrosin-residue phosphorylation (p-Tyr)-specific antibody to detect the state of phosphorylation. Among SFKs, only phosphorylation of Fyn significantly increased after Thy1 activation (Fig. 8A) . This result was confirmed by immunoprecipitation using anti-Fyn mAb, followed by immunoblotting with anti-phosphotyrosine antibody (Fig. 8B) .
To further examine the critical role Fyn plays in FasL upregulation by Thy1, we downregulated Fyn expression using specific siRNA. Fyn or control (nontarget) siRNA transfected myofibroblasts were activated by anti-Thy1 mAb or control IgG. Following Thy1 activation, (14, 15) . In myofibroblasts, these cytokines cause increased nitrite production (NO 2 -), but not FasL expression (Fig. 4) . The absence of FasL upregulation by IFN-B and TNF-A has also been reported by others in dermal fibroblasts (9) and human tracheal epithelial cell lines (31).
This indicates that another factor is responsible for the upregulation of FasL in fibroblasts.
In the lung, there are two subpopulations of fibroblasts, which are distinguished by expression of Thy1 (24, 25) . We asked whether Thy1 expressed on lung fibroblasts has a role in FasL upregulation. We show FasL expression on Thy1-negative myofibroblasts isolated from the total lung fibroblast population of untreated WT mice by FACS cell sorting, indicating that Thy1 is not necessary for a basal expression of FasL (Fig. 1) . However, following bleomycin treatment, FasL was upregulated in Thy1-positive but not in Thy1-negative myofibroblasts isolated from the lungs of WT mice following sorting (Fig. 1) ; further, FasL was upregulated in myofibroblasts isolated from WT (Thy1 (Fig. 3) , we assume that not all Thy1 + primary myofibroblasts from bleomycin-treated mice were activated in the in vivo milieu, and therefore some do not express FasL. This further strengthens the fact that the upregulation of FasL on lung myofibroblasts correlates with Thy1 molecule expression only following activation, either directly by agonist G7 anti-Thy1 mAb, or as a result of the bleomycin-induced milieu.
The ligand of Thy1 has not yet been identified. However, it has been shown that human polymorphonuclear leukocytes (PMN) express putative Thy1 ligand, which is implicated in their binding to fibroblasts that express Thy1 (32) . We have previously shown that lung injury 1-3 days post IT of bleomycin is characterized by an influx of inflammatory cells including PMN leukocytes (33) . We therefore speculate that these cells may bind to myofibroblast Thy1 molecules, inducing lung myofibroblast activation. The increase of FasL expression on lung myofbroblasts isolated from bleomycin-treated mice at days 3, 7, and 14 after IT, but not at day 1, (29) , strengthens this speculation.
Thy1 requires crosslinking in order to transmit a signal. No physiological Thy1 crosslinking mechanism has been described, however we hypothesize that Thy1 ligand assembles in homodimers or trimers, and can thus crosslink the Thy1 molecule, as has been shown in the TNF ligand family (34) .
The most well known stimulus of FasL upregulation in lymphocytes is T cell receptor (TCR), which is a more potent activator than Thy1 (16) . However, in cells that lack TCR but express GPI surface protein (35) , FasL upregulation may be induced through activation of GPI proteins, including Thy1, in a manner resembling the process in lung myofibroblasts.
We further show that Thy1 activation in lung myofibroblasts initially causes translocation of FasL from cell cytoplasm to the cell membrane surface (Fig. 5) , and only later induces a de novo synthesis of FasL at the mRNA and protein levels (Fig. 6) . Our findings in lung myofibroblasts are consistent with previous studies in lymphocytes, showing that FasL is stored in specialized secretory lysosomes that deliver it to the surface of the cell membrane following activation (36) .
Activated myofibroblasts may use a mechanism for their recently demonstrated cytotoxic function (29) (30), and for escape from immune surveillance (30) , that is similar to the mechanism employed by lymphocytes with cytotoxic functions that respond promptly to extracellular stimuli (36) .
Cell surface FasL can be cleaved by metalloproteases (11, 12) , thus synthesis of new protein is necessary to maintain high levels of FasL expression at the cell surface. Indeed, we demonstrate a later elevation of the FasL mRNA and protein levels (Fig. 6) , allowing myofibroblasts to maintain FasL expression at the cell surface.
In addition to its contribution to the cytotoxic function of lymphocytes (2) and myofibroblasts (29, 30) , FasL can also regulate cell proliferation (37, 38) and autocrine apoptosis (39) of lymphocytes, and proliferation of neighboring Fas-expressing cells (40) . It may play similar roles vis a vis myofibroblasts. These possible functions of FasL expressed on myofibroblasts require further study.
SFKs are nonreceptor tyrosine kinases, known to mediate Thy1 signaling in T cells (20) . In fibroblasts, it has been shown that, at baseline, Thy1 (Fig. 7A) . Moreover, we show that SFKs are responsible for the upregulation of FasL expression in myofibroblasts by Thy1 (Fig. 7B ).
Our findings of SFK phosphorylation following Thy1 activation are supported by similar findings following TSP-1/hep I stimulation (41) . The involvement of Src-like protein tyrosine kinases (PTK) with FasL induction was also shown in T lymphocytes following TCR engagement (42).
As mentioned above, FasL stored in secretory lysosomes is released to the cell surface upon cell stimulation (36, 43) . The targeting motif for secretory lysosome localization was identified as a proline-rich region (PRD) of FasL cytoplasmic tail (44) . It has been shown that the PRD of FasL binds Fgr, Fyn, and Lyn, but not Lck tyrosine kinases, leading to phosphorylation of FasL. Loss of phosphorylation reduces internalization of FasL into secretory lysosome (45) . Consistent with these findings, we show that Fyn was the only member of the SFK family with increased phosphorylation following myofibroblast Thy1 activation by G7 anti-Thy1 mAb (Fig. 8A-B) .
Moreover, we show that Fyn downregulation, using specific Fyn siRNA, reduced Thy1-induced FasL expression in lung myofibroblasts (Fig. 8C) .
The predominant histopathological finding of IPF is myofibroblast accumulation and collagen deposition in the extracellular matrix (46, 47) . Activated fibroblasts (myofibroblasts) are the key cellular source of the excessive extracellular matrix (ECM) deposition in lung fibrosis (48) .
Previous studies focused on the association between Thy1 expression and extracellular matrix production, or fibroblast proliferation and migration (19, 26, 28, 49) .We show an additional role cytotoxic cell phenotype in myofibroblasts (29, 30) , and may also alter the rate of lung myofibroblast proliferation.
In summary, we show here that in lung myofibroblasts, Thy1 is a functional protein, which transmits into the cell signals that upregulate the cell's FasL expression. This step may be critical in the development and persistence of lung fibrosis. 
